Beth H Shaz, MD

Transfusion Medicine

Associate Professor
Pathology & Laboratory Medicine

Other Appointments/Positions

Medical Director Blood Bank, Grady Memorial Hospital

Assistant Professor, Emory University School of Medicine

Pathology Division(s):
Clinical Pathology

Email Address:
bshaz@emory.edu

Education:

Bachelor of Science   (Chemical Engineering), With Distinction, Cornell University, - 1991

Medical Doctor   With Research Distinction, University of Michigan Medical Schoo, - 1996

Intern   General Surgery, Georgetown University, 1996 - 1997

Resident   Anatomic and Clinical Pathology, Beth Israel Deaconess Medical Center, 1997 - 2001

Fellow   Transfusion Medicine, Joint Program in Transfusion Medicine at Harvard Medical School, 2001 - 2002

Research Interests:

- Transfusion Medicine
My research interests are trauma induced coagulopathy, massive transfusion, effects of red blood cell transfusion and African American blood donation.

Clinical Focus:

I am the Blood Bank Medical Director at Grady Memorial Hospital. The unique clinical areas of this transfusion medicine service are supporting red cell transfusions to sickle cell patients and providing blood products to trauma victims.

Honors / Awards:

Howard Hughes Medical Institute Research Scholar, National Institutes of Health, 1993

National Science Foundation Fellowship, Cornell University, 1990

National Science Foundation Fellowship, Massachusetts Institute of Technology, 1989

Specialty Boards:

2001 Diplomate The American Board of Pathology, Anatomic and Clinical Pathology

2002 Diplomate The American Board of Pathology, Blood Banking/ Transfusion

Selected Publications:

Published and Accepted Research Articles -

Shaz BH, JC Zimring, DG Demmons, CD Hillyer. Blood donation and blood transfusion: Special considerations for African Americans. Transfusion Medicine Reviews 2008;22(3);202-214.

Hillyer CD, Shaz BH, Winkler AM, Reid M. Integrating molecular technologies for RBC typing and compatibility testing into blood centers and transfusion services. Transfusion Medicine Reviews 2008; 22(2):117-132.

Chan M, Malynn E, Shaz B, Uhl L. Utility of Consecutive Repeat HIT ELISA Testing for Heparin-Induced Thrombocytopenia. American Journal of Hematology 2008;83:212-217.

Shaz BH, Winters JL, Bandarenko N, Szczepiorkowski ZM. How we approach an apheresis request for a category III, category IV, or non-categorized indication. Transfusion 2007 ;47:1963-1971.

Shaz BH, Winters JL, Bandarenko N, Szczepiorkowski ZM. How we approach an apheresis request for a category III, category IV, or non-categorized indication. Transfusion 2007; 47:1963-1971.

Szczepiorkowski ZM, Shaz BH, Bandarenko N, Winters JL. The new approach to assignment of ASFA categories- Introduction to the fourth special issue: Clinical applications of therapeutic apheresis. Journal of Clinical Apheresis 2007; 22:96-105.

Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL. Guidelines on the use of therapeutic apheresis in clinical practice- Evidence-based approach from the apheresis applications committee of the American Society of Apheresis. Journal of Clinical Apheresis 2007; 22:106-175.

Shaz BH, Linenberger ML, Bandarenko N, Winters JL, Kim HC, Marques MB, Sarode R, Schwartz J, Weinstein R, Wirk A, Szczepiordowski ZM. Category IV indications for therapeutic apheresis- ASFA fourth special issue. Journal of Clinical Apheresis 2007; 22:176-180.

Shaz B, Goodarzi K, Malynn E, Uhl L. Improved Strategy for Mononuclear Cell Collection for donor Lymphocyte Infusions. Transfusion 2006;46:1044-1048.

Shaz BH, Reddy SI, Ayata G, Brien T, Farraye FA, Antonioli DA, Odze RD, Wang HH. Sequential clinical and histopahtological changes in collagenous and lymphocytic colitis over time. Modern Pathology. 2004;17:395-401.

Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis 2004;2:2133- 2137.

Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion 2004;44:1562-1566.

Ayata G, Ithamukkala S, Sapp H, Shaz BH, Brien TP, Wang HH, Antonioli DA, Farraye FA, Odze RD. Prevalance and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. American Journal of Surgical Pathology 2002;26:1414-1423.

Shaz BH, Reddy SI, Ayata G, Brien T, Farraye FA, Antonioli DA, Odze RD, Wang HH. Sequential clinical and histopahtological changes in collagenous and lymphocytic colitis over time. Modern Pathology. 2004;17:395-401.

Shaz B, Lewis WD, Skinner M, Khettry U. Explants from orthotopic liver transplantation for hereditary apolipoprotein A-1 amyloidosis are not suitable as "domino" donors. Modern Pathology 2001;14:577-588.

Shaz BH, Gordon F, Lewis DW, Jenkins RL, Skinner M, Khettry U. Orthotopic liver transplanation for familial amyloidotic polyneuropathy: A pathologic study. Human Pathology. 2000;31:40.

Yang S, Burgin AB, Huizenga BN, Roberson CA, Yao KC, Nash HA. A eucaryotic enzyme that can disjoin DNA and type I topoisomerases. Proceedings of the National Academy of Science 1996;93:11534-11539.

Burgin AB, Huizenga B, Nash HA. A novel suicide substrate for DNA topoisomerases and site- specific recombinases. Nucleic Acids Research 1995;23:2973-2979.

Bellamy WT, Odeley A, Huizenga B, Dalton WS, Weinstein RS, Hersh EM, Grogan TM. An in vivo model of human multidrug-resistant multiple myeloma in SCID mice. American Journal of Pathology 1993;142:691-698.

Books Edited and Written -

Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. Hillyer CD, Shaz BH, Zimring JC, Abshire TA, eds. Philadelphia, PA: Elsevier, 2009.